Get the Stockscreener App
168.85
1.44%
2.39
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Forecast
The First Trust Nyse Arca Biotechnology Index Fund (FBT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $153.83, representing a -8.90% decrease from the current price of $168.85. The highest analyst price target is $162.05, and the lowest is $145.61.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FBT Price Target
Average 157.92
(-6.47% Downside)
Is First Trust Nyse Arca Biotechnology Index Fund (FBT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.63 | Neutral |
| STOCH(9,6) | 21.16 | Neutral |
| STOCHRSI(14) | 43.51 | Neutral |
| MACD(12,26) | -1.5169 | Sell |
| ADX(14) | 25.39 | Sell |
| William %R | -54.54 | Neutral |
| CCI(14) | -29.40 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
168.44
Buy
|
167.99
Buy
|
| MA20 |
171.13
Sell
|
169.59
Sell
|
| MA50 |
171.00
Sell
|
169.83
Sell
|
| MA100 |
168.05
Buy
|
167.06
Buy
|
| MA200 |
159.43
Buy
|
161.99
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, FBT could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on FBT, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 47.63 indicates that FBT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 21.16 indicates that FBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 43.51 indicates that FBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.39 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -29.4 indicates that FBT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FBT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about First Trust Nyse Arca Biotechnology Index Fund financial reports and earnings history, First Trust Nyse Arca Biotechnology Index Fund (FBT) stock could reach $159.17 by 2030, $198.89 by 2040 and $213.95 by 2050. See the projected annual prices until 2050 of the First Trust Nyse Arca Biotechnology Index Fund stock below:
- First Trust Nyse Arca Biotechnology Index Fund (FBT) is expected to reach an average price of $167.74 in 2035, with a high prediction of $168.13 and a low estimate of $156.91. This indicates an $-0.66% rise from the last recorded price of $168.85.
- First Trust Nyse Arca Biotechnology Index Fund (FBT) stock is projected to chart a bullish course in 2040, with an average price target of $193.23, representing an $14.44% surge from its current level. The forecast ranges from a conservative $189.11 to a sky-high $198.89.
- Our analysts predict First Trust Nyse Arca Biotechnology Index Fund (FBT) to jump 10.65% by 2045, soaring from $180.80 to an average price of $186.84, potentially reaching $198.11. While $180.80 is the low estimate, the potential upside is significant.
- First Trust Nyse Arca Biotechnology Index Fund (FBT) stock is expected to climb by 2050, reaching an average of $213.94, a $26.70% jump from its current level. However, a wide range of estimates exists, with high and low targets of $213.95 and $201.38, respectively, highlighting the market's uncertainty.
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Year by Year Forecast
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2024
Our forecast for FBT stock price in 2024 now indicates an average price target of $146.89 with a high forecast of $162.05 and a low forecast of $131.74. The average prediction reflects an decrease of -13.00% from the last recorded price of $168.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $161.73 | $145.61 | $162.05 | -4.22% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2025
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) is expected to reach an average price of $157.92 in 2025, with a high prediction of $193.22 and a low estimate of $122.62. This indicates an -6.47% fall from the last recorded price of $168.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $158.97 | $157.75 | $166.48 | -5.85% |
| February, 2025 | $154.11 | $153.01 | $167.04 | -8.73% |
| March, 2025 | $152.35 | $148.57 | $168.81 | -9.77% |
| April, 2025 | $142.79 | $122.62 | $162.21 | -15.43% |
| May, 2025 | $167.67 | $138.84 | $170.32 | -0.70% |
| June, 2025 | $173.81 | $158.63 | $179.03 | +2.94% |
| July, 2025 | $183.29 | $168.52 | $183.29 | +8.55% |
| August, 2025 | $185.83 | $176.95 | $188.40 | +10.06% |
| September, 2025 | $178.85 | $176.89 | $193.22 | +5.92% |
| October, 2025 | $166.18 | $162.42 | $180.38 | -1.58% |
| November, 2025 | $169.88 | $162.11 | $172.69 | +0.61% |
| December, 2025 | $165.39 | $162.97 | $178.04 | -2.05% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2026
The predicted value for First Trust Nyse Arca Biotechnology Index Fund (FBT) in 2026 is set at an average of $181.19. Estimates vary from a peak of $199.21 to a trough of $163.18, indicating an +7.31% surge from the present price of $168.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $174.12 | $163.18 | $179.21 | +3.12% |
| February, 2026 | $185.99 | $171.17 | $186.12 | +10.15% |
| March, 2026 | $188.98 | $178.50 | $191.07 | +11.92% |
| April, 2026 | $189.53 | $187.45 | $199.21 | +12.25% |
| May, 2026 | $176.09 | $167.01 | $188.58 | +4.29% |
| June, 2026 | $171.58 | $167.57 | $179.03 | +1.62% |
| July, 2026 | $175.44 | $168.06 | $180.88 | +3.90% |
| August, 2026 | $187.76 | $171.77 | $189.41 | +11.20% |
| September, 2026 | $185.82 | $182.43 | $188.47 | +10.05% |
| October, 2026 | $186.91 | $176.32 | $188.26 | +10.69% |
| November, 2026 | $186.69 | $178.35 | $188.21 | +10.57% |
| December, 2026 | $178.84 | $178.01 | $188.90 | +5.92% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for First Trust Nyse Arca Biotechnology Index Fund (FBT) is $158.74, with a high forecast of $182.80 and a low forecast of $134.69. This indicates an -5.99% decrease from the last price of $168.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $176.92 | $173.87 | $179.26 | +4.78% |
| February, 2027 | $172.25 | $170.68 | $182.80 | +2.02% |
| March, 2027 | $176.47 | $163.60 | $177.00 | +4.51% |
| April, 2027 | $167.02 | $162.86 | $179.29 | -1.09% |
| May, 2027 | $161.86 | $151.51 | $164.80 | -4.14% |
| June, 2027 | $156.47 | $150.72 | $167.56 | -7.33% |
| July, 2027 | $162.10 | $149.58 | $165.10 | -4.00% |
| August, 2027 | $156.37 | $156.37 | $170.17 | -7.39% |
| September, 2027 | $151.57 | $137.41 | $157.47 | -10.23% |
| October, 2027 | $140.94 | $134.69 | $151.05 | -16.53% |
| November, 2027 | $156.74 | $140.30 | $157.27 | -7.17% |
| December, 2027 | $160.94 | $149.53 | $163.29 | -4.68% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2028
In 2028, First Trust Nyse Arca Biotechnology Index Fund (FBT) is projected to reach an average price of $160.37, with a high projection of $179.15 and a low estimate of $141.58. This indicates an -5.02% fall from the last price of $168.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $150.67 | $148.39 | $162.93 | -10.77% |
| February, 2028 | $145.05 | $141.58 | $159.05 | -14.09% |
| March, 2028 | $156.52 | $144.16 | $158.16 | -7.30% |
| April, 2028 | $165.79 | $154.35 | $167.98 | -1.81% |
| May, 2028 | $168.25 | $163.44 | $173.56 | -0.36% |
| June, 2028 | $174.58 | $164.02 | $176.22 | +3.40% |
| July, 2028 | $172.69 | $171.78 | $179.15 | +2.27% |
| August, 2028 | $161.10 | $159.44 | $175.93 | -4.59% |
| September, 2028 | $170.71 | $160.33 | $170.79 | +1.10% |
| October, 2028 | $168.44 | $162.70 | $172.49 | -0.24% |
| November, 2028 | $170.04 | $165.23 | $174.55 | +0.70% |
| December, 2028 | $166.38 | $163.74 | $174.64 | -1.46% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2029
The 2029 price forecast for First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) is $159.18 on average, with a high prediction of $174.77 and a low estimate of $143.59. This represents an -5.73% decrease from the previous price of $168.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $169.07 | $162.35 | $171.71 | +0.13% |
| February, 2029 | $166.57 | $162.81 | $168.09 | -1.35% |
| March, 2029 | $164.23 | $164.18 | $169.72 | -2.73% |
| April, 2029 | $158.10 | $156.02 | $164.37 | -6.37% |
| May, 2029 | $148.53 | $143.59 | $160.02 | -12.04% |
| June, 2029 | $156.81 | $147.08 | $156.81 | -7.13% |
| July, 2029 | $171.41 | $156.49 | $172.83 | +1.52% |
| August, 2029 | $162.31 | $162.31 | $174.77 | -3.87% |
| September, 2029 | $164.19 | $157.66 | $165.08 | -2.76% |
| October, 2029 | $166.59 | $163.59 | $170.39 | -1.34% |
| November, 2029 | $155.11 | $153.79 | $168.84 | -8.14% |
| December, 2029 | $158.33 | $154.93 | $165.50 | -6.23% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2030
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) is expected to reach an average price of $158.21 in 2030, with a high forecast of $181.30 and a low forecast of $135.12. This signifies an -6.30% decrease from the last price of $168.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $157.05 | $152.42 | $159.17 | -6.99% |
| February, 2030 | $160.95 | $156.65 | $167.67 | -4.68% |
| March, 2030 | $160.35 | $158.59 | $164.91 | -5.03% |
| April, 2030 | $153.50 | $151.91 | $161.93 | -9.09% |
| May, 2030 | $148.84 | $147.43 | $157.43 | -11.85% |
| June, 2030 | $153.85 | $144.14 | $155.66 | -8.88% |
| July, 2030 | $166.61 | $153.64 | $166.96 | -1.33% |
| August, 2030 | $176.66 | $168.50 | $177.12 | +4.63% |
| September, 2030 | $177.43 | $169.82 | $179.24 | +5.08% |
| October, 2030 | $179.14 | $165.48 | $179.50 | +6.09% |
| November, 2030 | $148.00 | $139.29 | $181.30 | -12.35% |
| December, 2030 | $153.52 | $135.12 | $157.50 | -9.08% |
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):